Asian Phytoceuticals PCL (BKK: APCO)

Asian Phytoceuticals PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Jan 1, 2020
Cash & Equivalents	53.5	125.63	82.15	98.59	100.2	160.28
Short-Term Investments	88.21	102.01	61.25	32.23	0.53	319.51
Trading Asset Securities	182.88	23.54	35.75	36.09	71.3	-
Cash & Short-Term Investments	324.59	251.19	179.15	166.92	172.04	479.79
Cash Growth	46.10%	40.21%	7.33%	-2.98%	-64.14%	-3.22%
Accounts Receivable	1.67	0.89	0.98	0.54	1.75	0.91
Other Receivables	2.21	3.34	3.23	2.74	3.54	0.53
Receivables	3.87	4.22	4.21	3.29	5.29	1.44
Inventory	57.41	44.27	52.88	59.94	62.33	62.28
Prepaid Expenses	1.19	0.9	0.92	0.67	0.71	0.66
Other Current Assets	0.22	0.23	0.35	0.3	0.35	0.35
Total Current Assets	387.29	300.82	237.51	231.11	240.72	544.52
Property, Plant & Equipment	70.06	82.34	64.02	91.21	113.39	71.36
Long-Term Investments	2.95	303.86	365.01	346.73	331.93	3.61
Other Intangible Assets	0.65	0.79	0.24	0.36	0.5	0.66
Long-Term Deferred Tax Assets	10.69	10.75	7.11	5.05	4.16	4.03
Other Long-Term Assets	160.48	6.17	6.25	6.07	6.08	5.58
Total Assets	632.13	704.72	680.15	680.53	696.78	629.76
Accounts Payable	2.91	1.2	0.64	1.99	0.63	0.69
Accrued Expenses	17.88	16.47	14.46	14.07	16.87	19.35
Current Portion of Leases	13.35	13.45	12.2	18.74	18.42	-
Current Income Taxes Payable	2.65	10.77	12.7	9.64	9.01	7.86
Current Unearned Revenue	0.26	0.26	0.31	0.32	0.26	0.26
Other Current Liabilities	3.72	4.05	4.78	2.99	3.68	3.04
Total Current Liabilities	40.77	46.2	45.1	47.75	48.87	31.2
Long-Term Leases	14.28	22.22	1.62	15.49	31.59	-
Other Long-Term Liabilities	4.04	4.04	4.04	5.01	3.4	3.4
Total Liabilities	80.22	92.34	69.64	85.54	101.31	50.57
Common Stock	300	300	300	300	300	300
Additional Paid-In Capital	166.94	166.94	166.94	166.94	166.94	166.94
Retained Earnings	99.4	161.63	146.3	126.75	125.26	112.25
Comprehensive Income & Other	-17.77	-18.88	-5.27	1.3	3.26	-
Total Common Equity	548.57	609.7	607.98	594.99	595.46	579.19
Minority Interest	3.34	2.69	2.53	-	-	-
Shareholders' Equity	551.91	612.39	610.51	594.99	595.46	579.19
Total Liabilities & Equity	632.13	704.72	680.15	680.53	696.78	629.76
Total Debt	27.63	35.67	13.82	34.23	50.01	-
Net Cash (Debt)	296.97	215.52	165.33	132.69	122.02	479.79
Net Cash Growth	34.96%	30.36%	24.60%	8.74%	-74.57%	-3.22%
Net Cash Per Share	0.50	0.36	0.28	0.22	0.20	0.80
Filing Date Shares Outstanding	600	600	600	600	600	600
Total Common Shares Outstanding	600	600	600	600	600	600
Working Capital	346.52	254.62	192.42	183.36	191.84	513.33
Book Value Per Share	0.91	1.02	1.01	0.99	0.99	0.97
Tangible Book Value	547.92	608.91	607.74	594.64	594.96	578.53
Tangible Book Value Per Share	0.91	1.01	1.01	0.99	0.99	0.96
Land	-	8.29	8.29	8.29	8.29	8.29
Buildings	-	93.72	91.07	91.04	94.77	94.31
Machinery	-	82.71	82.49	82.74	86.03	82.3

Source: S&P Capital IQ. Standard template. Financial Sources.